Status:
NOT_YET_RECRUITING
Mapping Diabetes in Quebec: Validating Medico-administrative Algorithms for Type 1 Diabetes, Type 2 Diabetes and LADA
Lead Sponsor:
Universite du Quebec en Outaouais
Collaborating Sponsors:
McGill University
Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Conditions:
Diabetes Mellitus, Type 1
Diabete Type 2
Eligibility:
All Genders
1-40 years
Brief Summary
The goal of this observational study is to validate medico-administrative algorithms that classify diabetes phenotypes (Type 1, Type 2, and Latent Autoimmune Diabetes in Adults - LADA) in a population...
Detailed Description
The goal of this observational study is to validate the effectiveness of medico-administrative algorithms developed to classify diabetes phenotypes, specifically Type 1, Type 2, and Latent Autoimmune ...
Eligibility Criteria
Inclusion
- Individuals diagnosed with Type 1, Type 2, or Latent Autoimmune Diabetes in Adults (LADA) based on clinical or self-reported data.
- Participants diagnosed between 1997 and 2024.
- Residents of Quebec with available medico-administrative records from 1997 to 2024.
Exclusion
- Non-residents of Quebec during the study period.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
17271 Patients enrolled
Trial Details
Trial ID
NCT06573905
Start Date
January 1 2025
End Date
June 30 2025
Last Update
January 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philippe Corsenac
Montreal, Quebec, Canada, J8X 3X7